Summit to Host Conference Call to Discuss Exclusive License and Collaboration Agreement With Sarepta Therapeutics for European Rights to Summit’s Utrophin Modulator Pipeline for the Treatment of Duchenne Muscular Dystrophy

World News: . []

OXFORD United LINK  Oct 04 2016 GLOBE NEWSWIRE -- Summit Therapeutics plc NASDAQSMMT LINK  the drug discovery and development company LINK  therapies for Duchenne LINK  dystrophy DMD and infection LINK  that i n conju...

More news and information about Summit Therapeutics plc

Published By:

Globe Newswire: 12:01 GMT Tuesday 4th October 2016

Published: .

Search for other references to "summit" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us